CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia.
| Autor: | Gamage, Udani1,2, Warnakulasuriya, Kesari1,3, Hansika, Sonali1, Silva, Gayathri N.1 gayathris@chem.cmb.ac.lk |
|---|---|
| Zdroj: | Thalassemia Reports. Mar2023, Vol. 13 Issue 1, p51-69. 19p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|